Immediate Impact
2 by Nobel laureates 1 from Science/Nature 36 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
Works of Inbal Golan‐Tripto being referenced
Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study
2023
Modified Tal Score: Validated score for prediction of bronchiolitis severity
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Inbal Golan‐Tripto | 157 | 132 | 46 | 55 | 55 | 370 | |
| Behnaz Ansari | 42 | 108 | 63 | 47 | 53 | 411 | |
| Patrick Stafler | 245 | 141 | 79 | 18 | 36 | 411 | |
| Zhichun Feng | 186 | 65 | 63 | 105 | 74 | 393 | |
| Ömer Kılıç | 117 | 78 | 95 | 35 | 49 | 389 | |
| Lijie Gao | 52 | 83 | 56 | 44 | 51 | 398 | |
| E Freundlich | 61 | 78 | 39 | 49 | 29 | 300 | |
| István Szegedi | 80 | 125 | 42 | 16 | 50 | 394 | |
| Soo Ahn Chae | 82 | 84 | 62 | 28 | 47 | 349 | |
| H Jouan | 54 | 51 | 76 | 53 | 37 | 312 | |
| Misao Kageyama | 123 | 91 | 78 | 118 | 43 | 361 |
All Works
Login with ORCID to disown or claim papers
Loading papers...